| Previous close | 680.50 |
| Open | 674.50 |
| Bid | 644.50 x 226100 |
| Ask | 645.00 x 394900 |
| Day's range | 642.50 - 674.50 |
| 52-week range | 642.50 - 961.00 |
| Volume | 642,975 |
| Avg. volume | 1,033,209 |
| Market cap | 4.75B |
| Beta | N/A |
| PE ratio (TTM) | 20.79 |
| EPS (TTM) | 31 |
| Earnings date | 16 Nov 2017 |
| Dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.50 |
Capital Cube•20 days agoMediclinic International Plc : Overvalued relative to peers, but good fundamentals
Categories: Yahoo FinanceMediclinic International Plc relative valuation is now OVERVALUED. It was previously rated UNDERVALUED, and has a fundamental analysis score of 75. Our analysis is based on comparing Mediclinic International Plc with the following peers – NMC Health PLC, G4S plc, National Express Group PLC and Capio AB (NMC-GB, GFS-GB, NEX-GB and CAPIO-SE). Relative Valuation Mediclinic ... Read more (Read more...)
- Reuters - UK Focus•2 months ago
South Africa's Mediclinic says CEO to retire next year
The chief executive of South Africa's Mediclinic International (LSE: MDC.L - news) will retire next year after eight years in the role, the private healthcare group said on Tuesday. Danie Meintjes, a 22-year veteran of South Africa's largest private hospital group, oversaw the company's merger with Al Noor in 2015, which extended its reach into Abu Dhabi and moved Mediclinic's primary listing to London. Meintjes will retire on 31 July 2018, the company said, adding that it will start searching for a successor to facilitate a smooth transition, without giving more detail on the process.
Capital Cube•3 months agoMediclinic International Plc :MDC-GB: Earnings Analysis: For the six months ended March 31, 2017 : June 30, 2017
Categories: Yahoo FinanceGet free summary analysis Mediclinic International Plc reports financial results for the half-year ended March 31, 2017. Highlights Summary numbers: Revenues of GBP 1466 million, Net Earnings of GBP 119 million. Gross margins narrowed from 41.39% to 37.79% compared to the same period last year, operating (EBITDA) margins now 18.89% from 21.88%. Change in operating ... Read more (Read more...)
